A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 432 participants.
Also called NCT06834932
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 432 participants
- Sponsor
- Registry
-
NCT06834932
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China, Hong Kong SAR China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06834932. Randomized; triple masking; primary purpose treatment. Start 2024-12-06 (actual); primary completion 2027-02-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
- Condition
- Dyslipidaemia
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Rosuvastatin Dose 1
- Intervention (Drug)
- Rosuvastatin dose 2
- Intervention (Drug)
- AZD0780
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct06834932- Content hash
2f89cb0fadc29e0472110b7109fea40ec24d8679376e7f1fae60dac7749393e3